Prof Bernard Allaouchiche
Critical care — Hospices Civils de Lyon, France
Bernard Allaouchiche
LeadR Profile
Critical care
Subspecialties: Veterinary Medicine - Anesthesiology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 421
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 29
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 15
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractlity an open label prospective randomized study 2024-518251-31-00 — mortality, shock, septic | Phase 3 | Recruiting | 2024 |
| Labile Iron Removal by Adding the Iron Chelator MEX CD1 to Dialysate in Sepsis Associated Acute Kidney Injury NCT07236463 — continuous renal replacement therapy, pilot projects, chelating agents, pilots, safety, blood, iron chelating agents, kidney, sepsis, therapeutics, intensive care units, renal replacement therapy, jugular veins, blood circulation, veins, membranes, acute kidney injury, dialysis solutions, catheters | Phase 1/Phase 2 | Recruiting | 2026 |
| Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis NCT06781099 — myelodysplastic syndromes, solutions, chelation therapy, iron overload, therapeutics, outpatients, primary myelofibrosis, dialysis solutions | N/A | Recruiting | 2026 |
| Rhu pGSN for Acute Respiratory Distress Syndrome (ARDS) NCT05947955 — safety, saline solution, administration, intravenous, solutions, respiratory insufficiency, pneumonia, body weight, therapeutics, gelsolin, respiratory distress syndrome, infections, plasma | Phase 2 | Recruiting | 2024 |
| Observed Pharmacokinetic of Piperacillin Tazobactam Compared to Amikacin in ICU NCT03990467 — toxemia, piperacillin, tazobactam drug combination, shock, septic, pharmaceutical preparations, systemic inflammatory response syndrome, drug monitoring, piperacillin, tazobactam, sepsis, amikacin, therapeutics, intensive care units, plasma | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map